K&L Consulting Services Expands Partnership with Medidata Solutions

  K&L Consulting Services Expands Partnership with Medidata Solutions

   Leading Biostatistical Analysis and Data Management CRO Attains Medidata
   Accreditations to Offer End-to-End Clinical Research Support for US and
                               Chinese Sponsors

Business Wire

NEW YORK -- January 23, 2013

Strengthening its clinical research service offerings in China and the US,
contract research organization (CRO) K&L Consulting Services (K&L), Inc. has
expanded its relationship with Medidata Solutions (NASDAQ: MDSO) by achieving
multiple accreditations in the Medidata Clinical Cloud. With this milestone,
K&L is now accredited to provide services around the industry-leading Medidata
Rave^® system for electronic data capture (EDC) and clinical data management
(CDM) as well as randomization services utilizing Medidata Balance^TM.

With a focus on biostatistical analysis, data standardization and a prominent
presence in China, K&L joined the Medidata Partner Program in 2011 as a
Medidata Services Partner to help serve sponsors within Asia and abroad.
Impressed with Medidata’s standards-based approach to end-to-end clinical
development, K&L saw value in extending the partnership to take greater
advantage of Rave's easy-to-use platform and streamlined processes to help
sponsors prepare regulatory submissions. K&L is currently utilizing Medidata
Rave for several studies within Asia; and with its continued growth in the
region, it expects the Medidata platform to play a vital role in helping
sponsors streamline their clinical trials.

  *“Partnering with Medidata enables us to offer sponsors state-of-the-art
    solutions for the critically important activities of randomization,
    electronic data capture and clinical data management,” said Xin Ke, PhD,
    president, K&L. “The Medidata Clinical Cloud, combined with our
    sophisticated services, provides sponsors with a highly-valued offering
    that ultimately reduces risk and leads to faster drug approvals.”

The Medidata accreditations position K&L to serve as a single source for
Balance-related randomization design services and Rave-related services,
including end user training, study build, reporting, outputs, integrations and
migrations. Using Balance and Rave, sites can use just one browser
interface—Medidata Rave—to randomize subjects and manage clinical data entry
and reporting.

  *“With these accreditations, K&L strengthens its commitment to providing
    sponsors with increasing efficiencies across their clinical trials,” said
    Steve Heath, vice president of channel sales at Medidata Solutions. “We’re
    excited to collaborate with K&L to help life science organizations both in
    the US and the growing market in China.”

Medidata first announced its channel partner program in April 2005 to enable
select CROs and other service providers to offer implementation services for
the Medidata Rave system for EDC and CDM. Since then, the Medidata Partner
Program has grown to include more than 30 partners in the US, Europe and Asia,
ranging from smaller clinical consultancies to large, global CROs. The program
offers eight accreditations across the Medidata platform and supports partners
with a variety of on-demand resources to help them optimize sponsors’ clinical

Connect with Medidata:

  *Read our blog, Geeks Talk Clinical
  *Tweet this:#CRO K&L Consulting achieves accreditations in @Medidata
    Partner Program, expanding #clinical offerings in China and US
  *Follow us on Twitter: @Medidata
  *Find us on LinkedIn

About K&L Consulting Services, Inc.

K&L Consulting Services, Inc. is a contract research organization (CRO)
offering data management, biostatistics, statistical programming, and medical
writing as well as CDISC compliant eSubmission services to the pharmaceutical,
biotechnology and medical device industries worldwide. Their services
encompass end-to-end solutions utilizing industry data standards and rigorous
operating procedures that enhance a sponsor's ability to get their products
approved faster at minimum risk and lower cost in order to meet patients’
needs for advanced medicines.

About Medidata Solutions Worldwide

Medidata Solutions is a leading global provider of cloud-based clinical
development solutions that enhance the efficiency of customers’ clinical
trials. Medidata’s advanced platform lowers the total cost of clinical
development by optimizing clinical trials from concept to conclusion: from
study and protocol design, trial planning and budgeting, site negotiation,
clinical portal, trial management, randomization and trial supply management,
clinical data capture and management, safety events capture, medical coding to
business analytics. Our diverse life science customer base spans
biopharmaceutical companies, medical device and diagnostic companies, academic
and government institutions, CROs and other research organizations, and
includes more than 20 of the top 25 global pharmaceutical companies as well as
organizations of all sizes developing life-enhancing medical treatments and


Medidata Solutions Contact:
Geoff Curtis, 312-233-1253
K&L Consulting Services, Inc. Contact:
Kendall A. Smith, 215-283-6035 ext. 111
Press spacebar to pause and continue. Press esc to stop.